Atara Biotherapeutics Presents Positive Efficacy and Safety Results for Patients with Epstein-Barr Virus-Associated Leiomyosarcoma
Atara Biotherapeutics Highlights Next-Generation and Off-the-Shelf, Allogeneic CAR T Technologies and Pipeline
Atara Biotherapeutics and Moffitt Cancer Center Announce Strategic Collaboration to Develop Next-Generation CAR T Immunotherapies
Atara Biotherapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Recent Operational Progress
Freegold Drills 1.43 g/t Au over 74.9 m at Golden Summit as 50,000 m 2026 Drill Program Accelerates Towards PFS
Thistle Resources Inc Commences Trading on the TSX Venture Exchange and Introduces the Middle River Gold Project
LaFleur Minerals Strengthens Leadership with Former Probe Gold and Probe Mines Executives to Accelerate Exploration Growth and Beacon Gold Mill Restart
Homerun Resources Inc. Announces Commencement of Trading of Sponsored BDR's on the Brazil B3 Stock Exchange
